(Q39719705)

English

Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease

scientific article published on 2 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease (English)

1 reference

Europe PubMed Central

14 September 2017

author name string

C J Yong-Kee

1

1 reference

Europe PubMed Central

14 September 2017

D Salomonczyk

2

1 reference

Europe PubMed Central

14 September 2017

J E Nash

3

1 reference

Europe PubMed Central

14 September 2017

publication date

2 April 2010

1 reference

Europe PubMed Central

14 September 2017

Neurotoxicity Research

1 reference

Europe PubMed Central

14 September 2017

19

1 reference

Europe PubMed Central

14 September 2017

4

1 reference

Europe PubMed Central

14 September 2017

519-526

1 reference

Europe PubMed Central

14 September 2017

https://scigraph.springernature.com/pub.10.1007/s12640-010-9174-2

0 references

Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Ubiquitin-proteasome system and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Biochemical, physiological and medical aspects of ubiquinone function

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Neuroprotection by pharmacologic blockade of the GAPDH death cascade

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Oxidative stress in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Activation of chaperone-mediated autophagy during oxidative stress

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Pathophysiology of the basal ganglia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Levodopa/dopamine replacement strategies in Parkinson's disease--future directions

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Mitochondrial disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Caffeine and progression of Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Recent developments in the pharmacological treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9174-2

21 January 2018

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine (3-hydroxytyramine) and brain function

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteolysis: from the lysosome to ubiquitin and the proteasome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20361292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12640-010-9174-2

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39719705&oldid=2089129226"